Homing in on the TOPAZ-1 Trial in Biliary Tract Cancer
Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss the phase 3 TOPAZ-1 trial in advanced biliary tract cancer.
Source: onclive.com
Biliary Tract News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biliary Tract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biliary Tract Today - Breaking & Trending Today
Ex-England star Kieron Dyer, 45, who underwent liver transplant last year is banned from driving for 12 months after cameras caught him speeding at 109mph in 70 zone
Dyer was caught breaking the 70mph limit in an Audi A6 at around 1:00am on March 1 last year on the A14 dual carriageway near Bar Hill, Cambridgeshire.
Source: dailymail.co.uk
Glenmark inks licensing pact with Jiangsu Alphamab, 3D Medicines for cancer drug
Under the agreement, Glenmark will get the license for KN035 (Envafolimab) in India, Asia Pacific, the Middle East, Africa, Russia, CIS, and Latin America, the company said in a statement.
Source: moneycontrol.com
Latest News | Glenmark Inks Licensing Pact with Jiangsu Alphamab, 3D Medicines for Cancer Drug
Get latest articles and stories on Latest News at LatestLY. Glenmark Pharmaceuticals Ltd on Thursday said its arm Glenmark Specialty S A (GSSA) has signed a license agreement with Jiangsu Alphamab Biopharmaceuticals Co and 3D Medicines (Beijing) Co Ltd for KN035 (Envafolimab), used in cancer treatment. Latest News | Glenmark Inks Licensing Pact with Jiangsu Alphamab, 3D Medicines for Cancer Drug.
Source: latestly.com
Jiangsu Alphamab Biopharmaceuticals, 3D Medicines (Beijing) and Glenmark announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World
Bengaluru : Glenmark Specialty S.A. (GSSA), a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark), today announced the signing of a license agreement with JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD (Jiangsu Alphamab) and 3D MEDICINES (BEIJING) C
Source: indiaeducationdiary.in